CD274 and central nervous system cancer: A recent study describes that loss of ATRX, another epigenetic modulator in both adult and pediatric glioma (20), epigenetically induces the expression of PD-L1 and several immunosuppressive cytokines, eliciting tolerogenic mechanisms in ATRX-mutant glioma (61).